Yahoo
NasdaqCM - Delayed Quote USD

Quoin Pharmaceuticals, Ltd. (QNRX)

4.5400 +0.4200 (+10.19%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
19,145.1440
16,290.7160
9,528.4650
9,378.5040
9,257.7040
Operating Income
-19,145.1440
-16,290.7160
-9,528.4650
-9,378.5040
-9,257.7040
Net Non Operating Interest Income Expense
481.6860
482.0810
558.4910
694.6140
-618.3360
Other Income Expense
-1.8570
3.9800
7.5020
-2.6830
494.5440
Pretax Income
-18,665.3150
-15,804.6550
-8,962.4720
-8,686.5730
-9,381.4960
Net Income Common Stockholders
-18,665.3150
-15,804.6550
-8,962.4720
-8,686.5730
-9,446.7620
Diluted NI Available to Com Stockholders
-18,665.3150
-15,804.6550
-8,962.4720
-8,686.5730
-9,446.7620
Basic EPS
-5.67
-14.80
-66.85
-337.47
-1.64k
Diluted EPS
-5.67
-14.80
-66.85
-337.47
-1.64k
Basic Average Shares
2,190.4990
1,068.1520
133.9640
25.7410
5.7660
Diluted Average Shares
2,190.4990
1,068.1520
133.9640
25.7410
5.7660
Total Expenses
19,145.1440
16,290.7160
9,528.4650
9,378.5040
9,257.7040
Net Income from Continuing & Discontinued Operation
-18,665.3150
-15,804.6550
-8,962.4720
-8,686.5730
-9,381.4960
Normalized Income
-18,663.4580
-15,808.6350
-8,969.9740
-8,683.8900
-9,798.8030
Interest Income
481.6860
482.0810
558.4910
694.6140
95.7450
Interest Expense
--
--
--
0
714.0810
Net Interest Income
481.6860
482.0810
558.4910
694.6140
-618.3360
EBIT
-19,145.1440
-16,290.7160
-9,528.4650
-9,378.5040
-8,667.4150
EBITDA
-19,045.1440
-16,190.7160
-9,428.4650
-9,274.7980
-8,563.3720
Reconciled Depreciation
100
100
100
103.7060
104.0430
Net Income from Continuing Operation Net Minority Interest
-18,665.3150
-15,804.6550
-8,962.4720
-8,686.5730
-9,381.4960
Total Unusual Items Excluding Goodwill
-1.8570
3.9800
7.5020
-2.6830
417.3070
Total Unusual Items
-1.8570
3.9800
7.5020
-2.6830
417.3070
Normalized EBITDA
-19,043.2870
-16,194.6960
-9,435.9670
-9,272.1150
-8,980.6790
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 8/1/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: